November
2
2025
Effective November 2, 2025, LifeLabs Ontario will update its current instrumentation to a fully Automated Indirect Immunofluorescence platform for the following tests, as part of our ongoing efforts to improve our quality of service.
- Anti-nuclear Antibody (ANA)
- Anti-endomysial Antibody (EMA)
- Anti-mitochondrial Antibody (AMA)
- Anti-parietal cell Antibody (APCA)
- Anti-smooth muscle Antibody (ASMA)
Changes to screening titres and interpretive comment enhancements will occur concurrently with instrumentation updates. Please note: There are no changes to collection, storage, or transportation requirements. There is no change in pricing for these tests, and the changes are being implemented for operational purposes. The current turnaround times are also expected to remain the same.
For more details click here.
